日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β-cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli-D study

在中国2型糖尿病患者中,根据基线β细胞功能评估iGlarLixi与IDegAsp的疗效和安全性:Soli-D研究的探索性分析

Gu, Weijun; Wu, Xiaohong; Zhang, Minlu; Wang, Xinyi; Du, Qin; Kang, Lei; Lauand, Felipe; Alvarez, Agustina; Mu, Yiming

Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial

使用 iGlarLixi 进行胰岛素治疗降阶:一项 4 期、开放标签、平行组随机对照试验

Novodvorský, Peter; Thieme, Lenka; Laňková, Ivana; Franková, Štěpánka; Veselá, Alica; Záhumenský, Emil; Edelsberger, Tomáš; Löblová, Marie; Žižka, Ondřej; Vytasil, Miroslav; Lauand, Felipe; Bonnemaire, Mireille; Hrubý, Filip; Mráz, Miloš; Haluzík, Martin

iGlarLixi provides improved early glycaemic control after 12 weeks of treatment compared with basal insulin in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN studies

在亚洲2型糖尿病患者中,与基础胰岛素相比,iGlarLixi治疗12周后可改善早期血糖控制:LixiLan-O-AP和LixiLan-L-CN研究的事后分析

Song, Lulu; Yuan, Xiaoyong; Huang, Shan; Zhang, Yawei; Lauand, Felipe; Wang, Zhini; Zhang, Jie; Du, Qin; Kang, Lei; Yang, Wenying; Guo, Xiaohui

Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli-SWITCH study

型糖尿病患者从预混胰岛素换用 iGlarLixi 的疗效和安全性:Soli-SWITCH 研究

Haluzík, Martin; Cypryk, Katarzyna; Alvarez, Agustina; Lauand, Felipe; Corp Dit Genti, Valérie; Bakiner, Okan Sefa; Lim, Soo

Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies

针对基础胰岛素控制不佳的2型糖尿病患者,比较iGlarLixi与IDegAsp的疗效和安全性:一项针对非亚洲研究的系统文献综述和网络荟萃分析

Home, Philip; Lauand, Felipe; Djaballah, Khier; Li, Xuan-Tony; Hafidh, Khadija; Mehta, Roopa; Faraoun, Khadra; Anaforoğlu, İnan; Serafini, Paul; Pourrahmat, Mir-Masoud

Evaluation of efficacy of iGlarLixi versus IDegAsp using derived time-in-ranges in Chinese adults with Type 2 diabetes: A post hoc analysis of the Soli-D study

利用衍生血糖达标时间评估 iGlarLixi 与 IDegAsp 在中国 2 型糖尿病成人患者中的疗效:Soli-D 研究的事后分析

Liu, Juan; Liu, Yu; Xu, Weiya; Zhang, Minlu; Huang, Qiong; Du, Qin; Kang, Lareina; Lauand, Felipe; Alvarez, Agustina; Li, Yanbing

Long-term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli-durability 24-month observational study

美国2型糖尿病患者长期使用iGlarLixi治疗的疗效:一项为期24个月的soli-durability观察性研究

Malik, Rayaz A; Anderson, John; Russo, Giuseppina; Amani, Mohammed E A; Adaş, Mine; Alvarez, Agustina; Lauand, Felipe; Li, Xuan; Khunti, Kamlesh

Effect of neurohormonal therapeutic in left ventricle global and regional function in Chagas cardiomyopathy in a translational animal experimental model

神经激素疗法对恰加斯病心肌病患者左心室整体和局部功能的影响:转化动物实验模型研究

Tanaka, Denise Mayumi; de Paula Dias Zara, Beatriz; Sapalo, André Timoteo; Vargas, Arthur Lauand; Marin-Neto, José Antonio; de Barros-Filho, Antônio Carlos Leite; Zinni, Cibele M Prado; Fonseca, Keila Cardoso Barbosa; de Oliveira, Maykon Tavares; Silva, João Santana; Ramires, Felix Jose Alvarez; de Lourdes Higuchi, Maria; Simões, Marcus Vinicius; Romano, Minna Moreira Dias

Neuropsychomotor Development of Children Exposed to SARS-CoV-2 in Utero During COVID-19 Pandemic

COVID-19 大流行期间子宫内暴露于 SARS-CoV-2 的儿童的神经精神运动发育

Motta, Felipe; Canellas-de-Castro, Maria Eduarda; Fernandes, Geraldo Magela; Sasaki, Lizandra Moura Paravidine; de Araújo Júnior, David Alves; Zaconeta, Alberto Moreno; da Silva, Ângelo Pereira; Gomes, Ciro Martins; Albuquerque, Cleandro Pires; Costa-Rocha, Ismael Artur; Santos, Janaina Araújo Teixeira; Jesus, José Alfredo Lacerda De; Costa, Karina Nascimento; Espindola, Laila Salmen; Mota, Licia Maria Henrique da; Lauand, Lucas; Castro, Luiz Cláudio Gonçalves de; Xavier, Marcelo Antônio Pascoal; Coelho-Dos-Reis, Jordana Grazziela Alves; Nóbrega, Otávio Toledo; Silva, Pabline Cavalcante da; Nery, Rodrigo de Resende; Santos, Wanessa Tavares; Tristão, Rosana Maria; Alves, Caroline Oliveira; Martins-Filho, Olindo Assis; Soares, Alexandre Anderson de Sousa Munhoz

Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli-D Study

在中国2型糖尿病成人患者中,使用iGlarLixi与IDegAsp进行早期血糖控制的比较:Soli-D研究的事后分析

Wu, Xiaohong; Zhang, Ying; Li, Ziling; Alvarez, Agustina; Lauand, Felipe; Melas-Melt, Lydie; Zhang, Minlu; Kang, Lei; Du, Qin; Zhang, Jie; Mu, Yiming